“One of the main challenges with diagnosing rare diseases is that health systems are simply not designed to detect them,” Noam Alon tells ISRAEL21c.
Alon is the CEO and cofounder of Impilo, an Israeli startup that has developed an…
“One of the main challenges with diagnosing rare diseases is that health systems are simply not designed to detect them,” Noam Alon tells ISRAEL21c.
Alon is the CEO and cofounder of Impilo, an Israeli startup that has developed an…